share_log

AbbVie | 4: Statement of changes in beneficial ownership of securities-Director Alpern Robert J

AbbVie | 4: Statement of changes in beneficial ownership of securities

艾伯維公司 | 4：持股變動聲明
SEC announcement ·  04/03 05:08
牛牛AI助理已提取核心訊息
In a recent transaction dated 03/31/2024, Robert J Alpern, associated with AbbVie Inc. [ABBV], has been involved in a financial activity concerning the company's stock. Unfortunately, the specific details regarding the nature of the transaction, such as the action type, status, number of shares involved, transaction price, and the resulting number of shares held after the action, have not been disclosed. This leaves a gap in the information necessary for investors to fully understand the implications of the transaction on their investment decisions.
In a recent transaction dated 03/31/2024, Robert J Alpern, associated with AbbVie Inc. [ABBV], has been involved in a financial activity concerning the company's stock. Unfortunately, the specific details regarding the nature of the transaction, such as the action type, status, number of shares involved, transaction price, and the resulting number of shares held after the action, have not been disclosed. This leaves a gap in the information necessary for investors to fully understand the implications of the transaction on their investment decisions.
在最近於2024年3月31日的一筆交易中，與艾伯維公司 [ABBV] 相關的羅伯特·阿爾珀恩參與了與該公司股票有關的金融活動。不幸的是，有關交易性質的具體細節，例如行動類型、狀態、所涉股票數量、交易價格以及行動後由此產生的持股數量，尚未披露。這在投資者充分了解交易對其投資決策的影響所必需的信息方面留下了空白。
在最近於2024年3月31日的一筆交易中，與艾伯維公司 [ABBV] 相關的羅伯特·阿爾珀恩參與了與該公司股票有關的金融活動。不幸的是，有關交易性質的具體細節，例如行動類型、狀態、所涉股票數量、交易價格以及行動後由此產生的持股數量，尚未披露。這在投資者充分了解交易對其投資決策的影響所必需的信息方面留下了空白。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。